A proposed scoring system for predicting mortality in melioidosis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 97, Issue 5, 2003, Pages 577-581

  Cheng, Allen C ^a   Jacups, Susan P ^a   Anstey, Nicholas M ^a,b   Curries, Bart J ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

Australia; Burkholderia pseudomallei; Melioidosis; Mortality; Multiple organ failure; Prognosis; Severity of illness index

Indexed keywords

BICARBONATE; BILIRUBIN; CEFTAZIDIME; MEROPENEM; UREA;

ADULT; AGE; ARTICLE; AUSTRALIA; BACTERIUM CULTURE; BURKHOLDERIA PSEUDOMALLEI; CLINICAL EXAMINATION; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DRUG UTILIZATION; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; INFORMATION PROCESSING; INTENSIVE CARE UNIT; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MELIOIDOSIS; MORTALITY; MULTIVARIATE ANALYSIS; PATHOGENESIS; PNEUMONIA; PREDICTION; PROSPECTIVE STUDY; RESUSCITATION; SCORING SYSTEM; HOSPITALIZATION; MICROBIOLOGY; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PREDICTION AND FORECASTING; PROGNOSIS; RISK;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA PSEUDOMALLEI;

FEMALE; HUMANS; MALE; MELIOIDOSIS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; NORTHERN TERRITORY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 7244234249     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)80035-4     Document Type: Article

References (18)

1. ACCP/SCCM American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Critical Care Medicine 20 1992 864-874
2. Chaowagul W. White N.J. Dance D.A. Wattanagoon Y. Naigowit P. Davis T.M. Looareesuwan S. & Pitakwatchara N. Melioidosis: A major cause of community-acquired septicemia in northeastern Thailand Journal of Infectious Diseases 159 1989 890-899
3. Currie B.J. Fisher D.A. Anstey N.M. & Jacups S.P. Melioidosis: Acute and chronic disease, relapse and re-activation Transactions of the Royal Society of Tropical Medicine and Hygiene 94 2000 301-304
4. Currie B.J. Fisher D.A. Howard D.M. Burrow J.N. Lo D. Selva-Nayagam S. Anstey N.M. Huffam S.E. Snelling P.L. Marks P.J. Stephens D.P. Lum G.D. Jacups S.P. & Krause V.L. Endemic melioidosis in tropical northern Australia: A 10-year prospective study and review of the literature Clinical Infectious Diseases 31 2000b 981-986
5. Dance D.A. Melioidosis: The tip of the iceberg? Clinical Microbiology Reviews 4 1991 52-60
6. Friedland J.S. Suputtamongkol Y. Remick D.G. Chaowagul W. Stricter R.M. Kunkel S.L. White N.J. & Griffin G.E. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection Infection and Immunity 60 1992 2402-2408
7. Hastie T. & Tibshirani R. Generalized Additive Models 1990 Chapman & Hall London
8. Lertmemongkolchai G. Cai G. Hunter C.A. Bancroft & G.J. Bystander activation of CD8(+) T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens Journal of Immunology 166 2001 1097-1105
9. Pettila V. Pettila M. Sarna S. Voutilainen P. & Takkunen O. Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill Critical Care Medicine 30 2002 1705-1711
10. Ramsay S.C. Ketheesan N. Norton R. Watson A.M. & LaBrooy J. Peripheral blood lymphocyte subsets in acute human melioidosis European Journal of Clinical Microbiology and Infectious Diseases 21 2002 566-568
11. Rivers E. Nguyen B. Havstad S. Ressler J. Muzzin A. Knoblich B. Peterson E. & Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock New England Journal of Medicine 345 2001 1368-1377
12. Royston P. & Ambler G. Generalized Additive Models (Stata module STB-42 sg79: Gam.ado) 1998 Royal Postgraduate Medical School, University College London London
13. Samuel M. & Ti T.Y. Interventions for Treating Melioidosis 2001 Update Software Ltd Oxford Cochrane Database of Systematic Reviews, No. 2, CD001263
14. Santanirand P. Harley V.S. Dance D.A. Drasar B.S. & Bancroft G.J. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei Infection and Immunity 67 1999 3593-3600
15. Simpson A.J. Suputtamongkol Y. Smith M.D. Angus B.J. Rajanuwong A. Wuthiekanun V. Howe P.A. Walsh A.L. Chaowagul W. & White N.J. Comparison of imipenem and ceftazidime as therapy for severe melioidosis Clinical Infectious Diseases 29 1999 381-387
16. Simpson A.J. Smith M.D. Weverling G.J. Suputtamongkol Y. Angus B.J. Chaowagul W. White N.J. van Deventer S.J. & Prins J.M. Prognostic value of cytokine concentrations (tumor necrosis factor- alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis Journal of Infectious Diseases 181 2000 621-625
17. Suputtamongkol Y. Hall A.J. Dance D.A. Chaowagul W. Rajchanuvong A. Smith M.D. & White N.J. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand International Journal of Epidemiology 23 1994 1082-1090
18. Walsh A.L. Smith M.D. Wuthiekanun V. Suputtamongkol Y. Chaowagul W. Dance D.A.B. Angus B. & White N.J. Prognostic significance of quantitative bacteremia in septicemic melioidosis Clinical Infectious Diseases 21 1995 1498-1500